Response to combined modality therapy correlates with survival in locally advanced non-small-cell lung cancer

International Journal of Radiation Oncology Biology Physics

Volumn 63, Issue 4, 2005, Pages 1029-1036

  Dong, Wook Kim ^a   Shyr, Yu ^a   Chen, Heidi ^a   Akerley, Wallace ^b   Johnson, David H ^a   Choy, Hak ^c  

^a VANDERBILT INGRAM CANCER CENTER   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Chemoradiation; Combined modality therapy; Non small cell lung cancer; Paclitaxel; Phase II; Response

Indexed keywords

DISEASES; HEALTH RISKS; MEDICAL PROBLEMS; PATIENT TREATMENT; TUMORS;

CHEMORADIATION; COMBINED MODALITY THERAPY; NON-SMALL-CELL LUNG CANCER; PACLITAXEL; PHASE II; RESPONSE;

RADIOTHERAPY;

CARBOPLATIN; PACLITAXEL;

ARTICLE; CALCULATION; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; HUMAN; LUNG NON SMALL CELL CANCER; MEASUREMENT; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; TREATMENT OUTCOME; TUMOR VOLUME;

ANALYSIS OF VARIANCE; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; CLINICAL TRIALS, PHASE II; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MULTICENTER STUDIES; PACLITAXEL; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 27144438654     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2005.03.055     Document Type: Article

References (37)

1. American Cancer Society Cancer facts and figures 2003 2003 American Cancer Society Atlanta
2. D.W. Kim, H. Choy Combined modality therapy for non-small cell lung cancer, past, present, and future Lung Cancer 42 Suppl. 2 2003 S35 S40
3. H. Choy, W. Akerley, H. Safran Phase I trial of outpatient weekly paclitaxel and concurrent radiation therapy for advanced non-small-cell lung cancer J Clin Oncol 12 1994 2682 2686
4. H. Choy, W. Akerley, H. Safran Multiinstitutional phase II trial of paclitaxel, carboplatin, and concurrent radiation therapy for locally advanced non-small-cell lung cancer J Clin Oncol 16 1998 3316 3322
5. H. Choy, R.F. Devore III, K.R. Hande A phase II study of paclitaxel, carboplatin, and hyperfractionated radiation therapy for locally advanced inoperable non-small-cell lung cancer (a Vanderbilt Cancer Center Affiliate Network study) Int J Radiat Oncol Biol Phys 47 2000 931 937
6. H. Choy, H. Safran, W. Akerley Phase II trial of weekly paclitaxel and concurrent radiation therapy for locally advanced non-small cell lung cancer Clin Cancer Res 4 1998 1931 1936
7. H. Choy, D.W. Kim, W. Akerley Combined modality therapy (CMT) using concurrent radiation therapy (RT) with paclitaxel based chemotherapeutic regimen in unresectable locally advanced nonsmall cell lung cancer (LANSCLC); Long term follow up on three sequential multi-institutional prospective phase II studies [Abstract] Proc Am Soc Clin Oncol 22 2003 638
8. C.A. Perez, M. Bauer, S. Edelstein Impact of tumor control on survival in carcinoma of the lung treated with irradiation Int J Radiat Oncol Biol Phys 12 1986 539 547
9. P.D. Maguire, L.B. Marks, G.S. Sibley 73.6 Gy and beyond Hyperfractionated, accelerated radiotherapy for non-small-cell lung cancer J Clin Oncol 19 2001 705 711
10. S. Narayan, G.T. Henning, R.K. Ten Haken Results following treatment to doses of 92.4 or 102.9 Gy on a phase I dose escalation study for non-small cell lung cancer Lung Cancer 44 2004 79 88
11. J.A. Hayman, M.K. Martel, R.K. Ten Haken Dose escalation in non-small-cell lung cancer using three-dimensional conformal radiation therapy Update of a phase I trial J. Clin Oncol 19 2001 127 136
12. M. Saunders, S. Dische, A. Barrett for the CHART Steering Committee. Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer A randomised multicentre trial Lancet 350 1997 161 165
13. M. Saunders, S. Dische, A. Barrett CHART Steering Committee Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer; mature data from the randomised multicentre trial Radiother Oncol 52 1999 137 148
14. C.P. Belani, W. Wang, D.H. Johnson Induction chemotherapy followed by standard thoracic radiotherapy (Std.TRT) vs. hyperfractionated accelerated radiotherapy (HART) for patients with unresectable stage III A & B non-small cell lung cancer (NSCLC) Phase III study of the Eastern Cooperative Oncology Group (ECOG 2597) Proc Am Soc Clin Oncol 22 2003 622 Abstract
15. H. Choy, W.J. Curran Jr, C.B. Scott Preliminary report of locally advanced multimodality protocol (LAMP) ACR 427 - A randomized phase II study of three chemo-radiation regimens with paclitaxel, carboplatin, and thoracic radiation (TRT) for patients with locally advanced non small cell lung cancer (LA-NSCLC) Proc Am Soc Clin Oncol 21 2002 291a
16. K. Furuse, M. Fukuoka, M. Kawahara Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer J Clin Oncol 17 1999 2692 2699
17. F. Pierre, P. Maurice, R. Gilles A randomized phase III trial of sequential chemo-radiotherapy versus concurrent chemo-radiotherapy in locally advanced non small cell lung cancer (NSCLC) (GLOT-GFPC NPC 95-01 study) Proc Am Soc Clin Oncol 20 2001 312a
18. W.J. Curran Jr, C.B. Scott, C.J. Langer Long-term benefit is observed in a phase III comparison of sequential vs. concurrent chemo-radiation for patients with unresected stage III NSCLC RTOG 9410 Proc Am Soc Clin Oncol 22 2003 622 Abstract
19. P.V. Zatloukal, L. Petruzelka, M. Zemanova Concurrent versus sequential radiochemotherapy with vinorelbine plus cisplatin (V-P) in locally advanced non-small cell lung cancer A randomized phase II study Proc Am Soc Clin Oncol 21 2002 290a
20. R.M. Huber, M. Schmidt, M. Flentje Induction chemotherapy and following simultaneous radio/chemotherapy versus induction chemotherapy and radiotherapy alone in inoperable NSCLC (Stage IIIA/IIIB) Proc Am Soc Clin Oncol 22 2003 622 Abstract
21. C. Schaake-Koning, W. van den Bogaert, O. Dalesio Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer N Engl J Med 326 1992 524 530
22. R. MacRae, Y. Shyr, D. Johnson Declining hemoglobin during chemoradiotherapy for locally advanced non-small cell lung cancer is significant Radiother Oncol 64 2002 37 40
23. L. Crino, P. Latini, M. Meacci Induction chemotherapy plus high-dose radiotherapy versus radiotherapy alone in locally advanced unresectable non-small-cell lung cancer Ann Oncol 4 1993 847 851
24. R.O. Dillman, J. Herndon, S.L. Seagren Improved survival in stage III non-small-cell lung cancer Seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial J Natl Cancer Inst 88 1996 1210 1215
25. R.O. Dillman, S.L. Seagren, K.J. Propert A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer N Engl J Med 323 1990 940 945
26. T. Le Chevalier, R. Arriagada, M. Tarayre Significant effect of adjuvant chemotherapy on survival in locally advanced non-small-cell lung carcinoma J Natl Cancer Inst 84 1992 58
27. P. Marino, A. Preatoni, A. Cantoni Randomized trials of radiotherapy alone versus combined chemotherapy and radiotherapy in stages IIIa and IIIb nonsmall cell lung cancer A meta-analysis Cancer 76 1995 593 601
28. D.H. Johnson, L.H. Einhorn, A. Bartolucci Thoracic radiotherapy does not prolong survival in patients with locally advanced, unresectable non-small cell lung cancer Ann Intern Med 113 1990 33 38
29. K. Mattson, L.R. Holsti, P. Holsti Inoperable non-small cell lung cancer Radiation with or without chemotherapy Eur J Cancer Clin Oncol 24 1988 477 482
30. R.F. Morton, J.R. Jett, W.L. McGinnis Thoracic radiation therapy alone compared with combined chemoradiotherapy for locally unresectable non-small cell lung cancer A randomized, phase III trial Ann Intern Med 115 1991 681 686
31. R.S. Pritchard, S.P. Anthony Chemotherapy plus radiotherapy compared with radiotherapy alone in the treatment of locally advanced, unresectable, non-small-cell lung cancer A meta-analysis Ann Intern Med 125 1996 723 729
32. S. Dische, M.I. Saunders The rationale for continuous, hyperfractionated, accelerated radiotherapy (CHART) Int J Radiat Oncol Biol Phys 19 1990 1317 1320
33. K. Kubota, K. Furuse, M. Kawahara Role of radiotherapy in combined modality treatment of locally advanced non-small-cell lung cancer J Clin Oncol 12 1994 1547 1552
34. J. Martin, R.J. Ginsberg, E.S. Venkatraman Long-term results of combined-modality therapy in resectable non-small-cell lung cancer J Clin Oncol 20 2002 1989 1995
35. K.S. Albain, C.B. Scott, V.R. Rusch Phase III comparison of concurrent chemotherapy plus radiotherapy (CT/RT) and CT/RT followed by surgical resection for stage IIIA(pN2) non-small cell lung cancer (NSCLC) Initial results from intergroup trial 0139 (RTOG 93-09) Abstract Proc Am Soc Clin Oncol 22 2003 621
36. A.T. Turrisi, C.B. Scott, V.R. Rusch Randomized trial of chemoradiotherapy to 61 Gy [no S] versus chemoradiotherapy to 45 Gy followed by surgery [S] using cisplatin etoposide in stage IIIa non-small cell lung cancer (NSCLC) Intergroup trial 0139, RTOG (9309) Int J Radiat Oncol Biol Phys 57 2003 S125 S126
37. M.P. MacManus, R.J. Hicks, J.P. Matthews Positron emission tomography is superior to computed tomography scanning for response-assessment after radical radiotherapy or chemoradiotherapy in patients with non-small-cell lung cancer J Clin Oncol 21 2003 1285 1292